VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
GLREGreenlight Capital Re, Ltd.
$16.07$533M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

GLRE logoGreenlight Capital Re, Ltd.(GLRE)Earnings, Financials & Key Ratios

GLRE•NASDAQ•Insurance & Managed Care
7.4× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryReinsuranceSub-IndustryProperty and casualty reinsurers
AboutGreenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. The company offers various property reinsurance products and services, including automobile physical damage, personal lines, and commercial lines. It also provides casualty reinsurance products and services comprising general liability, motor liability, professional liability, and worker's compensation; and accident and health, transactional liability, mortgage insurance, surety, trade credit, marine, energy, aviation, crop, cyber, political, and terrorism products. The company markets its products through reinsurance brokers. Greenlight Capital Re, Ltd. was incorporated in 2004 and is headquartered in Grand Cayman, the Cayman Islands.Show more
  • Revenue$696M+7.5%
  • Combined Ratio88.75%-4.8%
  • Net Income$75M+74.8%
  • Return on Equity11.14%+60.2%
  • Medical Cost Ratio59.11%-36.6%
  • Operating Margin11.25%+67.3%
  • Net Margin10.75%+62.6%
  • ROA3.58%+56.6%
  • Equity / Assets32.63%+3.5%

GLRE Key Insights

Greenlight Capital Re, Ltd. (GLRE) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Profitable underwriting: 88.8% combined ratio
  • ✓Strong 5Y profit CAGR of 80.9%
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Low loss ratio of 59.1%
  • ✓Trading at only 0.8x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when GLRE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

GLRE Price & Volume

Greenlight Capital Re, Ltd. (GLRE) stock price & volume — 10-year historical chart

Loading chart...

GLRE Growth Metrics

Greenlight Capital Re, Ltd. (GLRE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years18.93%
5 Years7.78%
3 Years13.39%
TTM7.94%

Profit CAGR

10 Years-
5 Years80.87%
3 Years43.47%
TTM78.22%

EPS CAGR

10 Years-
5 Years81.56%
3 Years50.23%
TTM82.91%

Return on Capital

10 Years-0.34%
5 Years3.85%
3 Years4.58%
Last Year6%

GLRE Recent Earnings

Greenlight Capital Re, Ltd. (GLRE) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 1/12 qtrs (50%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$1.05-16.0%
$1.25
Rev
$228M+41.7%
$161M
Q2 2026
Mar 9, 2026
Metric
Actual
Est
EPS
$1.44+28.6%
$1.12
Rev
$161M-9.3%
$178M
Q4 2025
Nov 3, 2025
Metric
Actual
Est
EPS
$0.13-229.4%
$0.10
Rev
$160M
—
Q3 2025
Aug 4, 2025
Metric
Actual
Est
EPS
$0.01+102.8%
$0.35
Rev
$178M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$1.05vs $1.25-16.0%
$228Mvs $161M+41.7%
Q2 2026Mar 9, 2026
$1.44vs $1.12+28.6%
$161Mvs $178M-9.3%
Q4 2025Nov 3, 2025
$0.13vs $0.10-229.4%
$160M
Q3 2025Aug 4, 2025
$0.01vs $0.35+102.8%
$178M
Based on last 12 quarters of dataView full earnings history →

GLRE Peer Comparison

Greenlight Capital Re, Ltd. (GLRE) competitors in Property and casualty reinsurers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
RNR logoRNRRenaissanceRe Holdings Ltd.Direct Competitor12.91B299.175.289.45%26.93%16.59%0.12
ACGL logoACGLArch Capital Group Ltd.Direct Competitor32.48B91.187.8514.27%22.07%19.02%0.11
MKL logoMKLMarkel CorporationDirect Competitor23.11B1847.1610.92-0.96%10.7%9.56%0.23
GLNG logoGLNGGolar LNG LimitedDirect Competitor5.05B49.6076.3151.14%30.1%6.4%1.33
PFSI logoPFSIPennyMac Financial Services, Inc.Direct Competitor4.3B82.388.86173.81%14.31%12.02%5.35
TRV logoTRVThe Travelers Companies, Inc.Product Competitor66.56B307.8111.225.17%12.88%19.12%0.28
HIG logoHIGThe Hartford Financial Services Group, Inc.Product Competitor35.27B128.259.637.1%14.13%22.01%0.23
AXS logoAXSAXIS Capital Holdings LimitedProduct Competitor7.45B100.998.189.05%16.18%16.93%0.23

Compare GLRE vs Peers

Greenlight Capital Re, Ltd. (GLRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs RNR

Most directly comparable listed peer for GLRE.

Scale Benchmark

vs MS

Larger-name benchmark to compare GLRE against a more recognizable public peer.

Peer Set

Compare Top 5

vs RNR, ACGL, MKL, GLNG

GLRE Income Statement

Greenlight Capital Re, Ltd. (GLRE) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue
645.67M243.85M491.4M478.82M570.46M477.63M632.35M647.97M696.35M706.45M
Revenue Growth %
9.74%-62.23%101.52%-2.56%19.14%-16.27%32.39%2.47%7.47%7.94%
Medical Costs & Claims
664.14M509.35M505.57M447.12M519.94M459.63M528.88M604.04M411.59M241.84M
Medical Cost Ratio %
102.86%208.88%102.88%93.38%91.14%96.23%83.64%93.22%59.11%34.23%
Gross Profit
-18.47M▲ 0%
-265.5M▼ 1337.5%
-14.17M▲ 94.7%
31.7M▲ 323.6%
50.52M▲ 59.4%
18M▼ 64.4%
103.46M▲ 475.0%
43.93M▼ 57.5%
284.76M▲ 548.2%
274.94M▲ 0%
Gross Margin %
-2.86%-108.88%-2.88%6.62%8.86%3.77%16.36%6.78%40.89%38.92%
Gross Profit Growth %
-125.29%-1337.54%94.66%323.63%59.4%-64.38%474.96%-57.54%548.21%-
Operating Expenses
26.36M88.5M-10.67M27.41M29.2M-6.53M16.53M365K206.45M227.54M
OpEx / Revenue %
4.08%36.29%-2.17%5.72%5.12%-1.37%2.61%0.06%29.65%32.21%
Depreciation & Amortization
368K2.77M2.35M2.3M16K79K0000
Combined Ratio %
106.94%245.17%100.71%99.1%96.26%94.87%86.25%93.28%88.75%66.44%
Operating Income
-44.83M▲ 0%
-354M▼ 689.7%
-3.5M▲ 99.0%
4.29M▲ 222.5%
21.32M▲ 397.1%
24.53M▲ 15.0%
86.93M▲ 254.4%
43.56M▼ 49.9%
78.31M▲ 79.8%
47.4M▲ 0%
Operating Margin %
-6.94%-145.17%-0.71%0.9%3.74%5.13%13.75%6.72%11.25%6.71%
Operating Income Growth %
-194.95%-689.73%99.01%222.47%397.06%15.02%254.44%-49.89%79.76%-
EBITDA
-44.46M-351.23M-1.15M6.59M21.34M24.61M94.96M52.75M83.1M50.58M
EBITDA Margin %
-6.89%-144.04%-0.23%1.38%3.74%5.15%15.02%8.14%11.93%7.16%
Interest Expense
02.5M6.26M6.28M17.92M10.92M8.03M9.18M4.79M3.21M
Non-Operating Income
0-2.5M-6.26M-6.28M-17.92M-10.92M-8.03M-9.18M-4.79M-3.17M
Pretax Income
-44.83M▲ 0%
-354M▼ 689.7%
-3.5M▲ 99.0%
4.29M▲ 222.5%
21.32M▲ 397.1%
24.53M▲ 15.0%
86.93M▲ 254.4%
43.56M▼ 49.9%
78.31M▲ 79.8%
83.27M▲ 0%
Pretax Margin %
-6.94%-145.17%-0.71%0.9%3.74%5.13%13.75%6.72%11.25%11.79%
Income Tax
-451K332K483K424K3.75M-816K100K749K3.48M2.08M
Effective Tax Rate %
1.01%-0.09%-13.79%9.88%17.57%-3.33%0.12%1.72%4.44%2.5%
Net Income
-44.95M▲ 0%
-350.05M▼ 678.7%
-3.99M▲ 98.9%
3.87M▲ 197.0%
17.58M▲ 354.7%
25.34M▲ 44.2%
86.83M▲ 242.6%
42.82M▼ 50.7%
74.83M▲ 74.8%
80.95M▲ 0%
Net Margin %
-6.96%-143.55%-0.81%0.81%3.08%5.31%13.73%6.61%10.75%11.46%
Net Income Growth %
-200.16%-678.73%98.86%196.99%354.68%44.17%242.63%-50.69%74.78%78.22%
EPS (Diluted)
-1.21▲ 0%
-9.74▼ 705.0%
-0.11▲ 98.9%
0.11▲ 200.0%
0.51▲ 363.6%
0.64▲ 25.5%
2.50▲ 290.6%
1.24▼ 50.4%
2.17▲ 75.0%
2.37▲ 0%
EPS Growth %
-200.83%-704.96%98.87%200%363.64%25.49%290.63%-50.4%75%82.91%
EPS (Basic)
-1.21-9.74-0.110.110.510.752.551.262.21-
Diluted Shares Outstanding
37M35.95M36.08M36.28M34.35M39.77M34.8M34.65M34.5M34.17M

GLRE Balance Sheet

Greenlight Capital Re, Ltd. (GLRE) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets
3.36B1.44B1.36B1.36B1.43B1.58B1.74B2.02B2.17B2.12B
Asset Growth %
26%-57.25%-5.59%0.18%5.14%10.71%9.8%16.19%7.62%28.11%
Total Investment Assets
1.21B36.91M256.44M196.15M230.97M178.2M332.18M387.14M633.08M4M
Long-Term Investments
1.21B36.91M240.06M166.74M230.97M178.2M332.18M387.14M633.08M2.42B
Short-Term Investments
0000000000
Total Current Assets
27.29M18.21M001.13B00884.5M1.43B1.28B
Cash & Equivalents
27.29M18.21M25.81M8.94M76.31M38.24M51.08M64.69M111.76M610.24M
Receivables
00278.12M353.18M416.46M518.79M645.09M790.27M745.77M3.08B
Other Current Assets
00-304.83M-362.12M634.79M-575.18M-713.43M0531.98M0
Goodwill & Intangibles
62.35M49.93M0063.03M079.96M099.95M198.43M
Goodwill
0000000000
Intangible Assets
62.35M49.93M0063.03M079.96M099.95M0
PP&E (Net)
-64.05M-51.36M00000000
Other Assets
727.77M1.07B-240.06M-166.74M5.88M-178.2M5.09M744.58M8.03M109.22M
Total Liabilities
2.51B955.98M878.01M892.79M951.83M1.08B1.14B1.38B1.46B1.38B
Total Debt
7.18M91.19M93.51M95.79M98.06M80.53M73.28M60.75M4.72M0
Net Debt
-20.11M72.97M67.7M86.86M21.75M42.3M22.2M-3.94M-107.03M-610.24M
Long-Term Debt
091.19M93.51M95.79M98.06M80.53M73.28M60.75M00
Short-Term Debt
000000004.72M0
Total Current Liabilities
838.98M866.97M00846.61M00127.77M1.45B0
Accounts Payable
838.98M139.22M122.67M92.25M91.22M105.14M68.98M105.89M95.85M0
Deferred Revenue
0000227.58M000361.7M0
Other Current Liabilities
-838.98M-148.86M-122.67M-92.25M527.8M-105.14M-68.98M21.88M984.07M0
Deferred Taxes
0000000000
Other Liabilities
0864.8M-93.51M-95.79M840.76M-80.53M1.02B1.19B15.46M1.38B
Total Equity
851.43M▲ 0%
479.46M▼ 43.7%
477.18M▼ 0.5%
464.86M▼ 2.6%
475.66M▲ 2.3%
503.12M▲ 5.8%
596.1M▲ 18.5%
635.88M▲ 6.7%
707.98M▲ 11.3%
741.17M▲ 0%
Equity Growth %
-4.52%-43.69%-0.48%-2.58%2.32%5.77%18.48%6.67%11.34%26.43%
Shareholders Equity
831.32M477.29M477.18M464.86M475.66M503.12M596.1M635.88M707.98M741.17M
Minority Interest
20.1M2.18M00000000
Retained Earnings
324.27M-26.08M-30.06M-27.08M-9.51M21.2M108.03M150.84M225.68M261.43M
Common Stock
3.74M3.64M3.7M3.45M3.38M3.48M3.53M3.48M3.39M0
Accumulated OCI
0000000000
Return on Equity (ROE)
-5.16%-52.6%-0.83%0.82%3.74%5.18%15.8%6.95%11.14%11.68%
Return on Assets (ROA)
-1.49%-14.61%-0.29%0.29%1.26%1.69%5.24%2.28%3.58%3.76%
Equity / Assets
25.36%33.4%35.21%34.24%33.32%31.84%34.35%31.54%32.63%34.89%
Debt / Equity
0.01x0.19x0.20x0.21x0.21x0.16x0.12x0.10x0.01x0.00x
Book Value per Share
23.0113.3413.2312.8113.8512.6517.1318.3520.5221.69
Tangible BV per Share
21.3311.9513.2312.8112.0112.6514.8318.3517.6221.69

GLRE Cash Flow Statement

Greenlight Capital Re, Ltd. (GLRE) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
94.42M-59.31M1.63M-91.32M-56.3M-31.8M7.51M111.5M210.21M237.08M
Operating CF Growth %
363.84%-162.81%102.75%-5699.2%38.36%43.51%123.61%1385.33%88.52%675.03%
Operating CF / Revenue %
14.62%-24.32%0.33%-19.07%-9.87%-6.66%1.19%17.21%30.19%33.56%
Net Income
-44.95M-354.33M-3.99M3.87M17.58M25.34M86.83M42.82M74.83M80.95M
Depreciation & Amortization
368K2.77M2.35M2.3M2.28M79K0000
Stock-Based Compensation
4.85M4.62M3.88M2.48M3.23M4.68M6.14M4.46M7.09M8.23M
Deferred Taxes
01.77M0-21.12M000000
Other Non-Cash Items
-40.3M328.72M-40.72M-750K-51.81M-58.59M-30.89M-31.8M-24.76M99.17M
Working Capital Changes
174.45M-42.86M40.1M-78.1M-27.57M-3.31M-54.57M96.03M153.05M48.73M
Cash from Investing
-106.53M-845.26M63.33M95.63M23.09M47.02M-53.13M-96.56M-149.17M-199.26M
Capital Expenditures
0000-1.23M-107.25M000-252K
Acquisitions
2.08M-13.65M-1.28M01.23M60.24M0000
Purchase of Investments
-1.15B-800.47M-50.14M-82.59M-119.6M-78.35M-7.14M0-165.43M-246.76M
Sale/Maturity of Investments
1.12B1.14B114.08M158.35M136.59M125.36M002.7M13.55M
Other Investing
-82.8M-1.17B671K19.87M6.1M47.02M-46M-96.56M13.56M34.2M
Cash from Financing
-2.82M80.07M0-17.78M-10M-19.83M-5.29M-21.24M-65.14M-69.19M
Dividends Paid
0000000-42.5M00
Share Repurchases
-2.82M-16.5M0-17.78M-10M-35K0-7.49M-9.82M-7M
Stock Issued
0000000000
Debt Issuance (Net)
01000K000-1000K-1000K-1000K-1000K-1.94M
Other Financing
000000042.5M0-37.81M
Net Change in Cash
-12.57M▲ 0%
-827.87M▼ 6484.5%
64.67M▲ 107.8%
-13.6M▼ 121.0%
-43.2M▼ 217.7%
-4.55M▲ 89.5%
-50.82M▼ 1016.1%
-6.64M▲ 86.9%
-5.36M▲ 19.4%
-32.52M▲ 0%
Exchange Rate Effect
2.36M-3.37M-290K-122K059K100K-345K-1.26M-1.15M
Cash at Beginning
39.86M1.53B703.23M767.91M754.31M711.1M706.55M655.73M649.09M643.73M
Cash at End
27.29M703.23M767.91M754.31M711.1M706.55M655.73M649.09M643.73M610.24M
Free Cash Flow
94.42M▲ 0%
-59.31M▼ 162.8%
1.63M▲ 102.8%
-91.32M▼ 5699.2%
-57.53M▲ 37.0%
-139.05M▼ 141.7%
7.51M▲ 105.4%
111.5M▲ 1385.3%
210.21M▲ 88.5%
237.08M▲ 0%
FCF Growth %
363.84%-162.81%102.75%-5699.2%37.01%-141.72%105.4%1385.33%88.52%128.13%
FCF Margin %
14.62%-24.32%0.33%-19.07%-10.08%-29.11%1.19%17.21%30.19%33.56%
FCF per Share
2.55-1.650.05-2.52-1.67-3.50.223.226.096.94

GLRE Key Ratios

Greenlight Capital Re, Ltd. (GLRE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio
106.94%245.17%100.71%99.1%96.26%94.87%86.25%93.28%88.75%66.44%
Medical Cost Ratio
102.86%208.88%102.88%93.38%91.14%96.23%83.64%93.22%59.11%34.23%
Return on Equity (ROE)
-5.16%-52.6%-0.83%0.82%3.74%5.18%15.8%6.95%11.14%11.68%
Return on Assets (ROA)
-1.49%-14.61%-0.29%0.29%1.26%1.69%5.24%2.28%3.58%3.76%
Equity / Assets
25.36%33.4%35.21%34.24%33.32%31.84%34.35%31.54%32.63%34.89%
Book Value / Share
23.0113.3413.2312.8113.8512.6517.1318.3520.5221.69
Debt / Equity
0.01x0.19x0.20x0.21x0.21x0.16x0.12x0.10x0.01x0.00x
Revenue Growth
9.74%-62.23%101.52%-2.56%19.14%-16.27%32.39%2.47%7.47%7.94%
Related:GLRE Dividend History·GLRE Revenue History·GLRE Price History·GLRE P/E History·GLRE Financial Ratios·GLRE Institutional Holders

GLRE SEC Filings & Documents

Greenlight Capital Re, Ltd. (GLRE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Apr 6, 2026·SEC

Material company update

Mar 9, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 9, 2026·SEC

FY 2025

Mar 10, 2025·SEC

FY 2024

Mar 5, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 4, 2025·SEC

GLRE Frequently Asked Questions

Greenlight Capital Re, Ltd. (GLRE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Greenlight Capital Re, Ltd. (GLRE) grew revenue by 7.5% over the past year. This is steady growth.

Yes, Greenlight Capital Re, Ltd. (GLRE) is profitable, generating $81.0M in net income for fiscal year 2025 (10.7% net margin).

Dividend & Returns

Greenlight Capital Re, Ltd. (GLRE) has a return on equity (ROE) of 11.1%. This is reasonable for most industries.

Industry Metrics

Greenlight Capital Re, Ltd. (GLRE) has a combined ratio of 88.8%. A ratio below 100% indicates underwriting profitability.

What if you invested $1,000 in GLRE back in 2005?

Total return calculator · dividends reinvested · 21+ years of data

See returns →

How much would $100/month in GLRE be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →